The Brisbane-headquartered firm is working alongside South Korea’s SK Bioscience and Germany-based IDT Biologika under a contract awarded by the European Health and Digital Executive Agency acting on behalf of the Health Emergency Preparedness and Response Authority.
EU backs Australian-led consortium with up to $250m to advance next-generation influenza vaccines
February 26, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
Australians turn to local pharmacies as frontline of everyday healthcare
March 13, 2026 - - Latest News -
Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer
March 13, 2026 - - Latest News -
The leadership challenge behind Australia’s medicine access gap
March 13, 2026 - - Latest News -
Australia has spent four decades having the wrong conversation about medicines access
March 13, 2026 - - Latest News -
‘An absolute medical miracle’ - MPs highlight progress and challenges at Cystic Fibrosis event
March 13, 2026 - - Latest News -
Australia’s top community pharmacists honoured at national awards
March 13, 2026 - - Latest News -
A new prostate cancer technology moves closer to global trials after strong early results
March 12, 2026 - - Australian Biotech

